Growth Metrics

Mannkind (MNKD) Gains from Sales and Divestitures (2012 - 2026)

Mannkind (MNKD) reported Gains from Sales and Divestitures of $246822.0 for Q1 2026, down 94.32% on a QoQ basis from $4.3 million in Q4 2025.

Mannkind (MNKD) has 15 years of Gains from Sales and Divestitures data on file, last reported at $246822.0 in Q1 2026.

  • Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $246822.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246822.0 (changed N/A YoY) and the FY2025 annual result came in at $4.3 million, down 0.69% from the prior year.
  • Gains from Sales and Divestitures slipped to $246822.0 in Q1 2026 per MNKD's latest filing, from $4.3 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $6.1 million in Q4 2023 and bottomed at $246822.0 in Q1 2026.
  • The 5-year median for Gains from Sales and Divestitures is $4.3 million (2025), against an average of $3.3 million.
  • The widest annual swing landed in 2023, when Gains from Sales and Divestitures surged 290.26%; it then dropped 27.65% in 2024.
  • Tracing MNKD's Gains from Sales and Divestitures over 5 years: stood at $1.6 million in 2022, then surged by 290.26% to $6.1 million in 2023, then retreated by 27.65% to $4.4 million in 2024, then declined by 0.69% to $4.3 million in 2025, then sank by 94.32% to $246822.0 in 2026.
  • Per Business Quant, the three latest MNKD Gains from Sales and Divestitures figures stand at $246822.0 (Q1 2026), $4.3 million (Q4 2025), and $4.4 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 246,822.00
Mar 31, 2026 246,822.00
Dec 31, 2025 4.35 Mn
Dec 31, 2025 4.35 Mn
Dec 31, 2024 4.38 Mn
Dec 31, 2024 4.38 Mn
Dec 31, 2023 6.05 Mn
Dec 31, 2023 6.05 Mn
Dec 31, 2022 1.55 Mn
Dec 31, 2022 1.55 Mn
Dec 31, 2021 1.52 Mn
Dec 31, 2021 1.52 Mn
Dec 31, 2020 1.73 Mn
Dec 31, 2020 1.73 Mn
Dec 31, 2019 804,105.00
Dec 31, 2019 804,105.00
Dec 31, 2018 694,831.00
Dec 31, 2018 694,831.00
Dec 31, 2017 192,361.00
Dec 31, 2017 192,361.00
Dec 31, 2016 131,000.00
Dec 31, 2016 131,000.00
Dec 31, 2015 1.11 Mn
Dec 31, 2015 1.11 Mn
Dec 31, 2014 6.98 Mn
Dec 31, 2014 6.98 Mn
Dec 31, 2013 2.86 Mn
Dec 31, 2013 2.86 Mn
Dec 31, 2012 1.28 Mn
Dec 31, 2012 1.28 Mn